Annual Meeting

Spotlighting the complex ballet of cancer cell death

Paula Amann
March 9, 2023

When he was an undergraduate at the University of Colombo in Sri Lanka, Nishanth Kuganesan undertook a solo study probing the impact of radiation treatments on chromosomes in lymphocytes, a family of white blood cells in the immune system. The small-scale study of blood samples had measurable results: He found evidence of cellular damage. And he also found a career path: research on the biology of cancer.

Kuganesan, who said he has been “very passionate about science” since his boyhood, is now a fifth-year doctoral student at the University of Toledo. Come April, he is set to defend his dissertation, which details nuances of ferroptosis, such as the critical roles of the gene TP53, dubbed the “guardian of the genome,” and the retinoblastoma/E2F checkpoint in curbing cancer.

Nishanth Kuganesan
Nishanth Kuganesan

As he considers his future, this Ph.D. candidate in cell and molecular biology dreams of making a difference in battling disease. “I really want to be in research and development … either in academia or in industry,” Kuganesan said.

He credits his advisor William Taylor, professor and associate chair of the biological sciences department at the University of Toledo, for providing him with room to grow as a scientist. “He has given me a lot of freedom to explore in his lab,” Kuganesan said.

There, Kuganesan discovered several new steps in the biochemical ballet of ferroptosis. “It didn’t make sense at the beginning,” he recalled.

But the pieces fell into place, and as first author of the paper based on his team’s work on the tumor suppressor p53, Kuganesan received a 2023 JBC Herbert Tabor Early Career Investigator Award.

Beyond the thrill of new knowledge, Kuganesan’s award-winning research on the intricate cellular dance of tumor suppression could help refine future steps in chemotherapy, he said.

“Our findings will help drug makers be cautious when they are making therapeutic drugs.”

No longer a linear pathway

Early in their study of the programmed cell death known as ferroptosis, Nishanth Kuganesan and his collaborators found that high levels of the tumor protein p53 heighten the destruction of cancer cells. Yet p21, a protein also known as cyclin-dependent kinase inhibitor 1, reins in ferroptosis. And they discovered something else: Overexpression of E2F, a family of genes that helps code for cell growth, also suppresses ferroptosis, with the involvement of p21.

E2F performs dual roles on the cellular stage. “E2F is essential for cells to function,” Kuganesan said. “In most cancer cells, it’s more than what’s needed, and this is the problem.”

Meanwhile, cyclin-dependent kinases and retinoblastoma proteins also play a part, stepping up to bar cancer cell death. Taken as a whole, the team’s recent study spotlights the complex interplay of the factors in ferroptosis. It’s as if several sets of conflicting choreography were being danced on the stage of tumor suppression.

“The whole thing was kind of unexpected,” Kuganesan said. “The linear pathway of the cell cycle in ferroptosis is not linear anymore.”

During the study, L.M. Viranga Tillekeratne, a University of Toledo professor of medicinal and biological chemistry, led the synthesis of CETZOLE-1, a novel small molecule. Kuganesan and his team used that substance to discover the mechanism of ferroptosis.

 “Tumor suppressor p53 promotes ferroptopsis in oxidative stress conditions independent of modulation of ferroptosis by p21, CDKs, RB, and E2F,” appeared in the Journal of Biological Chemistry in December 2021. Kuganesan and other winners of the JBC Tabor Award will give talks during a symposium on Sunday, March 26, at Discover BMB in Seattle.

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Paula Amann

Paula Amann is the ASBMB’s science writer. She brings more than 25 years of experience as a promotional writer, journalist and editor.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Offensive strategies in the lab
Feature

Offensive strategies in the lab

March 24, 2023

A love of football inspired this Iowa State undergrad’s food preservation research.

Lighting the way to undergraduate research
Annual Meeting

Lighting the way to undergraduate research

March 23, 2023

A team at Albion College is working on light-activated pharmaceuticals to target cancer and minimize damage to healthy cells.

Exploring marine science at the cellular level
Annual Meeting

Exploring marine science at the cellular level

March 21, 2023

Karlie Tischendorf, a senior at Purdue University, is scheduled to present her research on stingray venom at Discover BMB.

In memoriam: Christine Guthrie
In Memoriam

In memoriam: Christine Guthrie

March 20, 2023

She was a pioneer in RNA biology, a leader in the pre-mRNA splicing field and member of the ASBMB for almost 40 years.

How the ASBMB shaped my career
Essay

How the ASBMB shaped my career

March 16, 2023

The society helped me on my path from Ph.D. student to science policy professional.

JBC Tabor award winners to speak at Discover BMB
Annual Meeting

JBC Tabor award winners to speak at Discover BMB

March 16, 2023

These awards recognize early-career scientists for their standout first-author papers published in the past year.